347 studies found for:    Open Studies | "Prednisone"
Show Display Options
Rank Status Study
21 Recruiting Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Prednisone;   Drug: Deflazacort
22 Unknown  Effect of Steroids on Thrombosis (Blood Clot Formation) and Inflammation in Patients Undergoing Hip Surgery
Condition: Total Hip Replacement
Interventions: Drug: Prednisone;   Drug: Hydrocortisone;   Drug: Placebo (for Prednisone)
23 Recruiting Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT)
Condition: Multiple Myeloma
Interventions: Drug: Lenalidomide, endoxan, prednisone;   Drug: lenalidomide, endoxan, prednisone
24 Unknown  Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial
Conditions: Idiopathic Retroperitoneal Fibrosis;   Perianeurysmal Retroperitoneal Fibrosis;   Chronic Periaortitis
Interventions: Drug: Methotrexate+Prednisone;   Drug: Prednisone
25 Not yet recruiting Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
Condition: Langerhans Cell Histiocytosis
Interventions: Drug: Cytarabine;   Drug: Vinblastine/prednisone
26 Recruiting Study of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Carfilzomib
27 Recruiting Long-term Prednisone Use for End-stage Heart Failure
Conditions: Heart Failure;   Hyperuricemia
Intervention: Drug: prednisone
28 Recruiting A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Velcade;   Drug: Melphalan;   Drug: Prednisone;   Drug: Daratumumab
29 Recruiting Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin
Condition: Classical Hodgkin Lymphoma
Interventions: Drug: Bendamustine;   Drug: Prednisone;   Drug: Vinblastine;   Drug: Doxorubicin
30 Not yet recruiting Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: B Acute Lymphoblastic Leukemia;   B Lymphoblastic Lymphoma;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent B Lymphoblastic Lymphoma;   Recurrent T Lymphoblastic Leukemia/Lymphoma;   Refractory B Lymphoblastic Lymphoma;   Refractory T Lymphoblastic Lymphoma;   T Acute Lymphoblastic Leukemia;   T Lymphoblastic Lymphoma
Interventions: Drug: Asparaginase;   Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Drug: Etoposide;   Drug: Imatinib Mesylate;   Other: Laboratory Biomarker Analysis;   Drug: Prednisone;   Biological: Rituximab;   Drug: Vincristine Sulfate
31 Recruiting Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment in Quiescent Systemic Lupus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: prednisone discontinuation
32 Recruiting Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: enzalutamide;   Drug: abiraterone;   Drug: prednisone
33 Recruiting Corticosteroid Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
Condition: Chronic Rhinosinusitis Without Nasal Polyps
Interventions: Drug: Prednisone;   Drug: Topical mometasone
34 Not yet recruiting Low Dose Steroids in the Treatment of Nephrotic Syndrome Relapse
Condition: Glomerular Disease
Interventions: Drug: prednisone 60 mg/meter square Body Surface Area;   Drug: prednisone 45 mg;   Drug: prednisone 30 mg
35 Recruiting Prednisone for Heart Failure Patients With Hyperuricemia
Condition: Heart Failure, Hyperuricemia
Interventions: Drug: Prednisone;   Drug: Allopurinol
36 Recruiting Rituximab and Belimumab for Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Rituximab;   Drug: Cyclophosphamide;   Drug: Prednisone;   Drug: Methylprednisolone;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Biological: Belimumab
37 Recruiting Dexamethasone Versus Prednisone in Heart Failure Patients, Hospitalized With Exacerbation of Chronic Obstructive Pulmonary Disease.
Conditions: Heart Failure;   Chronic Obstructive Pulmonary Disease
Interventions: Drug: Dexamethasone;   Drug: Prednisone
38 Unknown  Pilot Study of How Children With Asthma Exacerbations Metabolize Prednisone
Condition: Asthma Exacerbation
Intervention: Drug: Prednisolone and prednisone
39 Recruiting Study of Treatment Response on IgG4 Related Disease (IgG4RD)
Condition: Autoimmune Disease
Interventions: Drug: Prednisone;   Drug: Prednisone and Mycophenolate mofetil
40 Recruiting A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: Ibrutinib;   Drug: Placebo;   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone (or equivalent)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years